Brendan M Ottemann - JoVE Visualize

Showing results (1-10 of 6) with videos related to

Pageof 1

Sort By:

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019

Development of Improved Tumor-Residualizing, GRPR-Targeted Agents: Preclinical Comparison of an Endolysosomal Trapping Approach in Agonistic and Antagonistic ConstructsWenting Zhang, Wei Fan, Brendan M Ottemann, et al.

Proteomics. Clinical Applications|August 30, 2016

Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II-mediated respirationKelly L Stauch, Lance M Villeneuve, Phillip R Purnell, et al.

Advanced Drug Delivery Reviews|November 14, 2018

Neurotheranostics as personalized medicinesBhavesh D Kevadiya, Brendan M Ottemann, Midhun Ben Thomas, et al.

Nanotheranostics|May 11, 2021

Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirsJonathan Herskovitz, Mahmudul Hasan, Jatin Machhi, et al.

Biomaterials|September 25, 2018

Bioimaging predictors of rilpivirine biodistribution and antiretroviral activitiesBrendan M Ottemann, Austin J Helmink, Wenting Zhang, et al.

Theranostics|January 2, 2018

Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell BiodistributionBhavesh D Kevadiya, Christopher Woldstad, Brendan M Ottemann, et al.

Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:

Pageof 1

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019

Development of Improved Tumor-Residualizing, GRPR-Targeted Agents: Preclinical Comparison of an Endolysosomal Trapping Approach in Agonistic and Antagonistic ConstructsWenting Zhang, Wei Fan, Brendan M Ottemann, et al.

Proteomics. Clinical Applications|August 30, 2016

Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II-mediated respirationKelly L Stauch, Lance M Villeneuve, Phillip R Purnell, et al.

Advanced Drug Delivery Reviews|November 14, 2018

Neurotheranostics as personalized medicinesBhavesh D Kevadiya, Brendan M Ottemann, Midhun Ben Thomas, et al.

Nanotheranostics|May 11, 2021

Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirsJonathan Herskovitz, Mahmudul Hasan, Jatin Machhi, et al.

Biomaterials|September 25, 2018

Bioimaging predictors of rilpivirine biodistribution and antiretroviral activitiesBrendan M Ottemann, Austin J Helmink, Wenting Zhang, et al.

Theranostics|January 2, 2018

Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell BiodistributionBhavesh D Kevadiya, Christopher Woldstad, Brendan M Ottemann, et al.

Pageof 1